Humalog Mix75/25 is a Subcutaneous Injection, Suspension in the Human Prescription Drug category. It is labeled and distributed by Eli Lilly And Company. The primary component is Insulin Lispro.
| Product ID | 0002-7511_18ce6abd-425e-43ac-9d3d-891cae15accf |
| NDC | 0002-7511 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Humalog Mix75/25 |
| Generic Name | Insulin Lispro |
| Dosage Form | Injection, Suspension |
| Route of Administration | SUBCUTANEOUS |
| Marketing Start Date | 1999-12-22 |
| Marketing Category | BLA / NDA |
| Application Number | BLA021017 |
| Labeler Name | Eli Lilly and Company |
| Substance Name | INSULIN LISPRO |
| Active Ingredient Strength | 100 [iU]/mL |
| Pharm Classes | Insulin [Chemical/Ingredient],Insulin Analog [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2000-10-10 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | BLA |
| Application Number | BLA021017 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2000-10-10 |
| Marketing Category | BLA |
| Application Number | BLA021017 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2007-12-07 |
| Ingredient | Strength |
|---|---|
| INSULIN LISPRO | 100 [iU]/mL |
| SPL SET ID: | c73da51a-1899-45ad-b6cf-9c52c36a25dd |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| PHarm Class EPC | |
| NUI Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0002-7510 | Humalog | Insulin lispro |
| 0002-7511 | Humalog | Insulin lispro |
| 0002-7512 | Humalog | Insulin lispro |
| 0002-7516 | Humalog | Insulin lispro |
| 0002-7712 | Humalog | Insulin lispro |
| 0002-7714 | Humalog | Insulin lispro |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() HUMALOG 74314093 1963572 Live/Registered |
Eli Lilly and Company 1992-09-15 |